Freshpet
FRPT
63.25
+0.48
+0.76%
Freshpet
US · FRPT
#2509 by market cap
Listed 1970
63.25
+0.48
+0.76%
Live - 5344 symbols - heartbeat 465s ago
· 2026-10-08 04:03
Pre-market
61.95
-2.06%
After-hours
63.25
0.00%
- Market cap
- 3.04B
- P/E (TTM)i
- 16.39
- P/Bi
- 2.46
- EPSi
- 2.64
- Div yieldi
- 0.00%
- 52W posi
- 42%
Reader sentiment
Are you bullish or bearish on FRPT?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 4.09, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +13.01% YoY
Margins
- Gross margin
- 40.80%
- Operating margin
- 6.87%
- Net margin
- 12.63%
Key ratios & quality
- Enterprise valuei
- 3.16B
- Altman Z-Scorei
- 4.09
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 193.24M | 245.86M | 318.79M | 425.49M | 595.34M | 766.90M | 975.18M | 1.10B |
| Gross profit | 89.99M | 114.20M | 132.91M | 162.15M | 186.03M | 250.87M | 395.96M | 449.63M |
| Selling & admin expenses | 94.88M | 114.45M | 134.91M | 186.81M | 238.02M | 281.32M | 357.96M | 373.95M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | -4.89M | -253.00K | -2.00M | -24.66M | -51.98M | -30.45M | 38.00M | 75.67M |
| Pretax profit | -5.28M | -1.24M | -3.12M | -27.53M | -55.48M | -31.51M | 47.52M | 70.77M |
| Tax | 77.00K | 144.00K | 65.00K | 162.00K | 282.00K | 210.00K | 598.00K | -68.36M |
| Net profit | -5.36M | -1.38M | -3.19M | -29.70M | -59.49M | -33.61M | 46.93M | 139.14M |
| Basic EPS | 0 | 0 | 0 | -1 | -1 | -1 | 1 | 3 |
| Diluted EPS | -0.15 | -0.04 | -0.08 | -0.69 | -1.29 | -0.70 | 0.93 | 2.64 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 263.25M | 264.69M | 288.85M | 285.23M | 297.64M | 305.59M |
| Gross profit | 103.79M | 108.19M | 114.19M | 123.46M | 120.67M | 128.69M |
| Selling & admin expenses | 115.29M | 90.39M | 89.29M | 78.99M | 116.34M | 106.99M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | -11.50M | 17.80M | 24.90M | 44.46M | 4.33M | 21.71M |
| Pretax profit | -12.56M | 16.25M | 23.71M | 43.38M | 65.64M | 25.60M |
| Tax | 134.00K | -102.00K | -77.96M | 9.56M | 17.13M | 6.11M |
| Net profit | -12.70M | 16.36M | 101.66M | 33.82M | 48.51M | 19.49M |
| Basic EPS | 0 | 0 | 2 | 1 | 1 | 0 |
| Diluted EPS | -0.26 | 0.33 | 1.86 | 0.64 | 0.91 | 0.39 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 30.96M | 54.32M | 109.10M | 150.33M | 261.97M | 427.32M | 437.00M | 435.71M |
| Cash & ST investments | 7.55M | 9.47M | 67.25M | 72.79M | 132.74M | 296.87M | 268.63M | 277.98M |
| Inventory | 9.32M | 12.54M | 19.12M | 35.57M | 58.29M | 63.24M | 80.79M | 76.77M |
| Total assets | 139.96M | 236.13M | 434.39M | 784.41M | 1.13B | 1.46B | 1.57B | 1.78B |
| Total current liabilities | 18.22M | 41.99M | 33.12M | 58.95M | 89.61M | 89.22M | 98.87M | 78.60M |
| Short-term debt | -- | 1.19M | 1.30M | 1.38M | 1.51M | 3.31M | 3.44M | 4.56M |
| Long-term debt | -- | 54.47M | -- | -- | -- | 393.07M | 395.16M | 397.33M |
| Total liabilities | 18,490,383.00 | 104,861,000.00 | 40,219,000.00 | 64,656,000.00 | 93,814,000.00 | 510,967,000.00 | 519,518,000.00 | 569,116,000.00 |
| Total equity | 121.47M | 131.27M | 394.17M | 719.75M | 1.03B | 953.45M | 1.06B | 1.21B |
| Retained earnings | -201.35M | -202.74M | -205.92M | -235.62M | -295.12M | -328.73M | -281.81M | -142.67M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 405.39M | 409.18M | 423.55M | 435.71M | 541.79M | 517.07M |
| Cash & ST investments | 243.73M | 243.68M | 274.59M | 277.98M | 381.38M | 350.81M |
| Inventory | 82.02M | 90.58M | 69.85M | 76.77M | 80.59M | 86.73M |
| Total assets | 1.56B | 1.65B | 1.75B | 1.78B | 1.84B | 1.81B |
| Total current liabilities | 82.57M | 84.98M | 76.75M | 78.60M | 87.65M | 85.52M |
| Short-term debt | 3.52M | 4.29M | 4.42M | 4.56M | 4.68M | 4.59M |
| Long-term debt | 395.70M | 396.24M | 396.78M | 397.33M | 397.88M | 398.44M |
| Total liabilities | 509,535,000.00 | 575,840,000.00 | 567,137,000.00 | 569,116,000.00 | 577,116,000.00 | 574,719,000.00 |
| Total equity | 1.05B | 1.07B | 1.18B | 1.21B | 1.26B | 1.24B |
| Retained earnings | -294.50M | -278.15M | -176.48M | -142.67M | -94.16M | -74.67M |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 18.58M | 16.32M | 21.19M | 647.00K | -43.23M | 75.94M | 154.29M | 160.56M |
| Depreciation & amortization | 14.07M | 15.92M | 21.13M | 30.47M | 34.56M | 58.52M | 73.62M | 89.72M |
| Free cash flow | 2.30M | -54.32M | -113.38M | -321.45M | -273.30M | -163.15M | -32.80M | 12.38M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | 0 | 0 | 252.06M | 332.17M | 337.51M | -- | -- | -- |
| Ending cash balance | 7.55M | 9.47M | 67.25M | 72.79M | 132.74M | 296.87M | 268.63M | 277.98M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 4.81M | 33.89M | 66.76M | 55.11M | 40.33M | 44.43M |
| Depreciation & amortization | 21.83M | 20.61M | 24.36M | 22.92M | 24.99M | 24.96M |
| Free cash flow | -21.68M | 445.00K | 31.56M | 2.06M | 12.73M | 14.70M |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 243.73M | 243.68M | 274.59M | 277.98M | 381.38M | 350.81M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | -4.50 | -1.09 | -1.21 | -5.33 | -6.79 | -3.39 | 4.67 | 12.29 |
| ROA %i | -3.92 | -0.74 | -0.95 | -4.87 | -6.23 | -2.60 | 3.09 | 8.30 |
| ROIC %i | -4.32 | -0.35 | -0.77 | -4.89 | -6.28 | -2.71 | 3.31 | 8.99 |
| 5-year avg ROE %i | -- | -3.19 | -2.72 | -3.19 | -3.79 | -3.56 | -2.41 | 0.29 |
| EBIT margin %i | -2.58 | -0.10 | -0.60 | -5.79 | -8.44 | -2.27 | 6.13 | 7.70 |
| FCF / sales %i | 1.19 | -- | -- | -- | -- | -- | -- | 1.12 |
| Current ratioi | 1.70 | 1.29 | 3.29 | 2.55 | 2.92 | 4.79 | 4.42 | 5.54 |
| Quick ratioi | 1.09 | 0.67 | 2.59 | 1.82 | 2.12 | 3.96 | 3.41 | 4.35 |
| Debt / assetsi | 0.00 | 27.13 | 1.93 | 0.90 | 0.51 | 29.03 | 26.93 | 27.84 |
| LT debt / equityi | -- | 47.90 | 1.80 | 0.79 | 0.41 | 44.23 | 39.86 | 40.58 |
| Interest coveragei | -16.84 | -0.25 | -1.58 | -8.55 | -9.65 | -1.24 | 4.88 | 6.01 |
| Revenue CAGR (3Y) %i | 18.48 | 23.76 | 27.90 | 30.10 | 34.28 | 33.99 | 31.85 | 22.78 |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- | -- | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 1.54 | 3.26 | 11.22 | 12.29 | 17.33 | 17.62 |
| ROA %i | 1.03 | 2.14 | 7.53 | 8.30 | 11.79 | 11.76 |
| ROIC %i | 1.20 | 2.48 | 8.15 | 8.99 | 12.55 | 12.47 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 2.85 | 4.58 | 5.58 | 7.70 | 14.36 | 14.64 |
| FCF / sales %i | -- | -- | 0.22 | 1.12 | 4.12 | 5.19 |
| Current ratioi | 4.91 | 4.81 | 5.52 | 5.54 | 6.18 | 6.05 |
| Quick ratioi | 3.71 | 3.58 | 4.42 | 4.35 | 5.10 | 4.87 |
| Debt / assetsi | 27.61 | 30.05 | 28.35 | 27.84 | 26.86 | 27.24 |
| LT debt / equityi | 40.68 | 45.80 | 41.61 | 40.58 | 38.77 | 39.51 |
| Interest coveragei | 2.29 | 3.50 | 4.22 | 6.01 | 11.46 | 12.32 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Fresh pet food products100.00%
Quote time 2026-10-08 04:03:49 · For reference only, not investment advice and not tailored to your situation.